Medicare Enrolled
Dr. Ronald Scott, M.D.
Interventional Cardiology · Longview, TX
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Scott from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Scott?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Scott
Dr. Ronald Scott is an interventional cardiology specialist in Longview, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Scott performed 5,884 Medicare services across 3,844 unique beneficiaries.
Between the years covered by Open Payments, Dr. Scott received a total of $12,448 from 40 pharmaceutical and/or device companies across 717 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Scott is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 9% volume in TX
$12,448 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,884
Medicare services
Top 9% in TX for interventional cardiology
3,844
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~310 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
752 | $85 | $287 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
656 | $44 | $152 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
482 | $10 | $45 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
481 | $22 | $92 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
413 | $6 | $23 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
325 | $139 | $599 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
257 | $4 | $15 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
244 | $8 | $34 |
| Heart muscle strain imaging | 240 | $28 | $107 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
216 | $19 | $72 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
199 | $56 | $156 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
178 | $48 | $203 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
178 | $98 | $1,718 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
174 | $328 | $1,273 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
119 | $65 | $195 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
110 | $10 | $134 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
91 | $26 | $184 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
88 | $19 | $73 |
| Cardiac catheterization | 78 | $186 | $819 |
| Tc-99m radiopharmaceutical, non-highly enriched uranium source This code covers the cost of Technetium-99m radiopharmaceuticals derived from non-highly enriched uranium sources. It is billed as an add-on per study dose for full cost recovery. |
73 | $10 | $13 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
45 | $9 | $40 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
45 | $18 | $67 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
40 | $117 | $439 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
39 | $10 | $40 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
39 | $39 | $106 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
37 | $102 | $371 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
35 | $62 | $196 |
| Pacemaker programming, single lead Adjustment and testing of a single-lead pacemaker to ensure it functions correctly. |
28 | $46 | $134 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
27 | $424 | $1,628 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
27 | $84 | $288 |
| Programming of multiple lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with multiple leads to ensure proper function. |
26 | $74 | $243 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
26 | $62 | $317 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
25 | $120 | $387 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording, analyzing, and interpreting a continuous external electrocardiogram (EKG) over a period of more than 48 hours up to 7 days. |
18 | $200 | $311 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 18 | $190 | $928 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
17 | $19 | $73 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
16 | $9 | $40 |
| Pacemaker insertion with heart chamber electrodes A surgical procedure to implant a pacemaker device and place electrodes into the upper and lower chambers of the heart to regulate heart rhythm. |
11 | $397 | $1,425 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 11 | $258 | $1,039 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
21.8% high complexity
25.3% medium
52.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,448
Total received (2018-2024)
Avg $1,778/year across 7 years
Top 38% in TX for interventional cardiology
40
Companies
717
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,434 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$14 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,399
2023
$1,959
2022
$1,691
2021
$2,360
2020
$450
2019
$1,415
2018
$2,174
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic Vascular, Inc.
$1,306
Novartis Pharmaceuticals Corporation
$1,290
Biosense Webster, Inc.
$1,174
Edwards Lifesciences Corporation
$1,054
Bard Peripheral Vascular, Inc.
$904
Janssen Pharmaceuticals, Inc
$682
Abbott Laboratories
$648
Merck Sharp & Dohme LLC
$511
E.R. Squibb & Sons, L.L.C.
$489
Medtronic, Inc.
$486
Boston Scientific Corporation
$434
Boehringer Ingelheim Pharmaceuticals, Inc.
$398
ShockWave Medical, Inc
$389
Gilead Sciences, Inc.
$308
Amgen Inc.
$305
Inari Medical, Inc.
$274
Cardiovascular Systems Inc.
$212
iRhythm Technologies, Inc.
$197
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$165
Alnylam Pharmaceuticals Inc.
$148
PFIZER INC.
$143
Philips Electronics North America Corporation
$121
SANOFI-AVENTIS U.S. LLC
$110
Kerecis Limited
$90
Shockwave Medical, Inc
$85
ABIOMED
$77
W. L. Gore & Associates, Inc.
$75
Novo Nordisk Inc
$54
Regeneron Healthcare Solutions, Inc.
$49
Actelion Pharmaceuticals US, Inc.
$35
Terumo Medical Corporation
$34
Teleflex LLC
$30
BOSTON SCIENTIFIC CORPORATION
$30
Chiesi USA, Inc.
$30
Amarin Pharma Inc.
$29
Lundbeck LLC
$20
BIOTRONIK INC.
$18
Acist Medical Systems, Inc.
$14
Lexicon Pharmaceuticals, Inc.
$14
AstraZeneca Pharmaceuticals LP
$14
Top 3 companies account for 30.3% of total payments
Associated products mentioned in payments ›
ASSURITY · AURORA EV-ICD MRI SURESCAN · AVEIR · AZURE XT DR MRI SURESCAN · Amplia MRI · Asahi Fielder XT cornary guide wire · Asahi Fielder coronary guide wire · Asahi Sion guide wire · Assurity Pacemaker · Azure · Baylis Medical Company Radiofrequency Puncture Generator · CAMZYOS · CARDIOMEMS · CARTO 3 · CHANTIX · COBALT DR MRI SURESCAN · CRT-Ds · Carto 3 · Carto 3 System · CartoSound · Catheter - Specialty Access · Catheter - Turnpike · Cobalt · Confidense · Confirm Rx · CoreValve Evolut · Corlanor · Diamondback Coronary · Diamondback Peripheral · Durata Defibrillation ICD Lead · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · EXCLUDER Conformable AAA Endoprosthesis with Active Control · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Ellipse ICD · FARXIGA · FLOWTRIEVER CATHETER · Fortify Assura · GORE DRYSEAL FLEX Introducer Sheath · GORE EXCLUDER Iliac Branch Endoprosthesis · General - Therapies · Glidesheath · Hi-Torque Pilot guide wire · IGT D Peripheral · IGT_D FM · Impella · Inpefa · JARDIANCE · KENGREAL · Kerecis Omega3 Wound · LEQVIO · LINQ II · LUTONIX · LifeVest · Lutonix Drug Coated Balloon · MICRA · MULTAQ · Merlin Connectivity and Remote · Micra · Mini Trek catheters · Multi-Link Mini Vision coronary stent system · MyCareLink Smart · NC TREK coronary catheters · NORTHERA · ONPATTRO · OPSUMIT · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Peripheral Orbital Atherectomy System · Quadra Allure MP RF CRT Pacemkr · ROTABLATOR · RXi Systems · Repatha · Resolute · Reveal LINQ · S · SAPIEN 3 Ultra RESILIA · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Soundstar · Spectranetics Undiv · TR BAND · TYRX · Telescope · ULTRASCORE · VERQUVO · Vascepa · VersaCross Access Solution · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WOLVERINE · XARELTO · Xience Alpine cornary stent system · Xience Sierra Coronary Stent System · ZIO XT Patch · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $212 per 100 Medicare services performed
Geographic Context
Interventional cardiologists within 10 mi
8
Per 100K population
6.4
County median income
$64,809
Nearest hospital
LONGVIEW REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Scott is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 9% in TX), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Scott experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Scott performed 752 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Scott receive payments from pharmaceutical companies?
Yes. Dr. Scott received a total of $12,448 from 40 companies across 717 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Scott's costs compare to other interventional cardiologists in Longview?
Dr. Scott's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Scott) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Longview
Browse interventional cardiologists in Longview ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in TX
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in TX
Which TX interventional cardiologists receive the most from drug and device companies.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Biosense Webster, Inc. Payments to Doctors
See all physicians who received payments from Biosense Webster, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology